Communiqués Veradigm Inc.

Actions

MDRX

US01988P1084

Equipement et technologie médicale avancés

Temps Différé OTC Markets Autres places de cotation 22:00:00 17/07/2026			Varia. 5j.	Varia. 1 janv.
4,750 ^USD	-3,06%		-5,94%	-1,04%

28/05	Transcript : Veradigm Inc. - Special Call
26/05	Veradigm Inc. publie ses résultats pour l'exercice clos le 31 décembre 2024	CI

Communiqués

28/05	Veradigm : Initial Statement of Beneficial Ownership (Form 3)	PU
06/04	Veradigm : Appoints Christian Greyenbuhl as Chief Financial Officer	PU
26/03	The CMS Advance Notice: What Medicare Advantage Plans Should Be Doing Now	PU
17/02	Veradigm : Provides Business and Strategy Update	PU
10/02	Veradigm : to Release Business Update February 17th and Host Investor Call February 18th	PU
02/02	Veradigm : Extends Stockholder Rights Plan	PU
10/11	Veradigm : Adds Sentara Health Plans to Veradigm Payer Insights Solution	PU
01/10/25	Veradigm : Provides 2025 Business Update	PU
28/08/25	Celebrating H1 2025 Success: Veradigm Network Honored with Industry Recognition	PU
26/08/25	Veradigm : Dr Lew Schon – Rock and Roll Orthopedic Innovator	PU
20/08/25	The Growing Challenge of Patient Payments: Why Manual, Paper-Based Billing Is Failing	PU
15/08/25	Veradigm : Exact Sciences’ Lab Connectivity Breakthrough with Veradigm DORN	PU
12/08/25	Veradigm : The Role of Real-World Evidence in Payer-Provider Collaboration	PU
07/08/25	Close Care Gaps with Confidence: How Veradigm Supports Independent Providers in Value-Based Care	PU
19/03/25	Veradigm : MDRX.PK - Q4 2024 Veradigm Inc Earnings Call - Transcript	PU
19/03/25	Veradigm : Provides Updates on Fiscal 2023 and 2024 and an Outlook for Fiscal 2025	PU
29/07/24	Veradigm : Material Agreement Form 8 K	PU
10/04/24	Veradigm : Material Event - Form 8-K	PU
01/04/24	Veradigm : Material Agreement - Form 8-K	PU
26/03/24	Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation	PR
13/03/24	Veradigm : 2024 Barclays Conference Presentation	PU
28/02/24	Veradigm Receives Expected Delisting Notice from Nasdaq	BU
28/02/24	Veradigm to Participate in TD Cowen Annual Health Care Conference	BU
27/02/24	Veradigm Provides Update on its Financial Restatement Process	BU
27/02/24	Veradigm to Acquire ScienceIO	BU